<p>SANUWAVE Health（纳斯达克代码：SNWV - 获取免费报告）在周三发布给投资者的报告中，被 Northland Capmk 的投资分析师上调至 “强力买入” 评级，Zacks.com 报道。</p>
<p>其他一些券商也对 SNWV 发表了看法。Northland Securities 在周三的一份研究报告中开始覆盖 SANUWAVE Health。他们对该股票设定了 “跑赢大盘” 的评级和 55.00 美元的目标价。Wall Street Zen 在 8 月 30 日（星期六）的一份研究报告中将 SANUWAVE Health 的评级从 “买入” 上调至 “强力买入”。最后，Roth Capital 在 8 月 22 日（星期五）的一份研究报告中将 SANUWAVE Health 的目标价从 54.00 美元上调至 55.00 美元，并给予该公司 “买入” 评级。一位研究分析师给予该股票 “强力买入” 评级，另外两位给予 “买入” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “买入”，平均目标价为 55.00 美元。</p>
<p>获取 <strong>SANUWAVE Health</strong> 警报：</p>
<p><strong>查看我们关于 SNWV 的最新研究报告</strong></p>
<h2>SANUWAVE Health 价格表现</h2>
<p>SANUWAVE Health 的股票在周三开盘价为 38.81 美元。SANUWAVE Health 的 52 周低点为 5.21 美元，52 周高点为 46.58 美元。该公司的市值为 3.326 亿美金，市盈率为-4.70，贝塔值为 1.39。该股票的 50 日简单移动平均线为 37.20 美元。</p>
<p>SANUWAVE Health（纳斯达克代码：SNWV - 获取免费报告）最近在 8 月 8 日（星期五）发布了季度财报。该公司报告季度每股收益为 0.01 美元，超出分析师共识预期的-0.09 美元 0.10 美元。该业务的季度收入为 1016 万美元，而分析师预期为 1014 万美元。SANUWAVE Health 已将其 2025 年第三季度的指引设定为每股收益。2025 财年的指引为每股收益。</p>
<h2>机构投资者对 SANUWAVE Health 的看法</h2>
<p>对该公司的对冲基金和其他机构投资者最近调整了持股。Solas Capital Management LLC 在第一季度购买了价值约 20658000 美元的 SANUWAVE Health 新股份。Strategic Investment Solutions Inc. IL 在第一季度购买了价值约 47000 美元的 SANUWAVE Health 新股份。AWM Investment Company Inc.在第一季度购买了价值约 18153000 美元的 SANUWAVE Health 新股份。Rhumbline Advisers 在第二季度购买了价值约 211000 美元的 SANUWAVE Health 新股份。最后，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度购买了价值约 126000 美元的 SANUWAVE Health 新股份。机构投资者持有该公司 42.53% 的股票。</p>
<h2>关于 SANUWAVE Health</h2>
<p>（获取免费报告）</p>
<p>SANUWAVE Health, Inc 是一家冲击波技术公司，研究、开发并商业化非侵入性、高能量和声学冲击波，用于再生医学及其他应用，覆盖美国及国际市场。其冲击波用于产生生物反应，使身体通过修复和再生组织以及肌肉骨骼和血管结构自我愈合。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，胜过 SANUWAVE Health</li>
<li>即将到来的 IPO 股票锁定期，解释</li>
<li>开学购物达到 400 亿美元：现在值得关注的三只零售股票</li>
<li>恒生指数是什么？</li>
<li>Alphabet 股票在躲避严厉的反垄断措施后飙升</li>
<li>保护您的投资组合免受冠状病毒传播的三只股票</li>
<li>为什么高通在经历数月滞后后表现优于 NVIDIA</li>
</ul>
<p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 SANUWAVE Health 吗？</h2>
<p>在考虑 SANUWAVE Health 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 SANUWAVE Health 并不在名单上。</p>
<p>虽然 SANUWAVE Health 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

SNWV

<p>Northland Capital Markets 将 SANUWAVE Health (NASDAQ:SNWV) 的评级上调至 “强力买入”。其他券商也对该股票给予了积极评价，普遍评级为 “买入”，平均目标价为 55.00 美元。SANUWAVE Health 的股票开盘价为 38.81 美元，52 周区间为 5.21 至 46.58 美元。该公司报告的季度每股收益为 0.01 美元，超出预期。机构投资者持有该股票的 42.53%，显示出对公司的强烈兴趣</p>

<p>Sanuwave Health (NASDAQ:SNWV - Get Free Report) was upgraded by investment analysts at Northland Capmk to a &#34;strong-buy&#34; rating in a note issued to investors on Wednesday,Zacks.com reports.</p>
<div class="lb-trans"><p>SANUWAVE Health（纳斯达克代码：SNWV - 获取免费报告）在周三发布给投资者的报告中，被 Northland Capmk 的投资分析师上调至 “强力买入” 评级，Zacks.com 报道。</p>
</div><p>A number of other brokerages have also weighed in on SNWV. Northland Securities started coverage on Sanuwave Health in a research report on Wednesday. They set an &#34;outperform&#34; rating and a $55.00 price objective on the stock. Wall Street Zen raised Sanuwave Health from a &#34;buy&#34; rating to a &#34;strong-buy&#34; rating in a research note on Saturday, August 30th. Finally, Roth Capital boosted their price objective on Sanuwave Health from $54.00 to $55.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, August 22nd. One research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of &#34;Buy&#34; and an average price target of $55.00.</p>
<div class="lb-trans"><p>其他一些券商也对 SNWV 发表了看法。Northland Securities 在周三的一份研究报告中开始覆盖 SANUWAVE Health。他们对该股票设定了 “跑赢大盘” 的评级和 55.00 美元的目标价。Wall Street Zen 在 8 月 30 日（星期六）的一份研究报告中将 SANUWAVE Health 的评级从 “买入” 上调至 “强力买入”。最后，Roth Capital 在 8 月 22 日（星期五）的一份研究报告中将 SANUWAVE Health 的目标价从 54.00 美元上调至 55.00 美元，并给予该公司 “买入” 评级。一位研究分析师给予该股票 “强力买入” 评级，另外两位给予 “买入” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “买入”，平均目标价为 55.00 美元。</p>
</div><p>Get <strong>Sanuwave Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>SANUWAVE Health</strong> 警报：</p>
</div><p><strong>View Our Latest Research Report on SNWV</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 SNWV 的最新研究报告</strong></p>
</div><h2>Sanuwave Health Price Performance</h2>
<div class="lb-trans"><h2>SANUWAVE Health 价格表现</h2>
</div><p>Sanuwave Health stock opened at $38.81 on Wednesday. Sanuwave Health has a 52 week low of $5.21 and a 52 week high of $46.58. The firm has a market cap of $332.60 million, a PE ratio of -4.70 and a beta of 1.39. The stock's fifty day simple moving average is $37.20.</p>
<div class="lb-trans"><p>SANUWAVE Health 的股票在周三开盘价为 38.81 美元。SANUWAVE Health 的 52 周低点为 5.21 美元，52 周高点为 46.58 美元。该公司的市值为 3.326 亿美金，市盈率为-4.70，贝塔值为 1.39。该股票的 50 日简单移动平均线为 37.20 美元。</p>
</div><p>Sanuwave Health (NASDAQ:SNWV - Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.10. The business had revenue of $10.16 million for the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.</p>
<div class="lb-trans"><p>SANUWAVE Health（纳斯达克代码：SNWV - 获取免费报告）最近在 8 月 8 日（星期五）发布了季度财报。该公司报告季度每股收益为 0.01 美元，超出分析师共识预期的-0.09 美元 0.10 美元。该业务的季度收入为 1016 万美元，而分析师预期为 1014 万美元。SANUWAVE Health 已将其 2025 年第三季度的指引设定为每股收益。2025 财年的指引为每股收益。</p>
</div><h2>Institutional Investors Weigh In On Sanuwave Health</h2>
<div class="lb-trans"><h2>机构投资者对 SANUWAVE Health 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently modified their holdings of the company. Solas Capital Management LLC bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $20,658,000. Strategic Investment Solutions Inc. IL bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $47,000. AWM Investment Company Inc. bought a new stake in shares of Sanuwave Health during the first quarter valued at approximately $18,153,000. Rhumbline Advisers bought a new stake in shares of Sanuwave Health during the second quarter valued at approximately $211,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Sanuwave Health during the second quarter valued at approximately $126,000. Institutional investors own 42.53% of the company's stock.</p>
<div class="lb-trans"><p>对该公司的对冲基金和其他机构投资者最近调整了持股。Solas Capital Management LLC 在第一季度购买了价值约 20658000 美元的 SANUWAVE Health 新股份。Strategic Investment Solutions Inc. IL 在第一季度购买了价值约 47000 美元的 SANUWAVE Health 新股份。AWM Investment Company Inc.在第一季度购买了价值约 18153000 美元的 SANUWAVE Health 新股份。Rhumbline Advisers 在第二季度购买了价值约 211000 美元的 SANUWAVE Health 新股份。最后，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度购买了价值约 126000 美元的 SANUWAVE Health 新股份。机构投资者持有该公司 42.53% 的股票。</p>
</div><h2>About Sanuwave Health</h2>
<div class="lb-trans"><h2>关于 SANUWAVE Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.</p>
<div class="lb-trans"><p>SANUWAVE Health, Inc 是一家冲击波技术公司，研究、开发并商业化非侵入性、高能量和声学冲击波，用于再生医学及其他应用，覆盖美国及国际市场。其冲击波用于产生生物反应，使身体通过修复和再生组织以及肌肉骨骼和血管结构自我愈合。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Sanuwave Health</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now</li>
<li>What is the Hang Seng index?</li>
<li>Alphabet Stock Surges After Dodging Harsh Antitrust Remedies</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Why Qualcomm Is Outperforming NVIDIA After Months of Lagging</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 SANUWAVE Health</li>
<li>即将到来的 IPO 股票锁定期，解释</li>
<li>开学购物达到 400 亿美元：现在值得关注的三只零售股票</li>
<li>恒生指数是什么？</li>
<li>Alphabet 股票在躲避严厉的反垄断措施后飙升</li>
<li>保护您的投资组合免受冠状病毒传播的三只股票</li>
<li>为什么高通在经历数月滞后后表现优于 NVIDIA</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Sanuwave Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 SANUWAVE Health 吗？</h2>
</div><p>Before you consider Sanuwave Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 SANUWAVE Health 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sanuwave Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 SANUWAVE Health 并不在名单上。</p>
</div><p>While Sanuwave Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 SANUWAVE Health 目前在分析师中获得 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

SANUWAVE Health（NASDAQ:SNWV）在 Northland Capmk 被升级为 “强力买入” 评级